Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (5 quarters reported)
$186M in Q4 2023 → $7.81M now. Hover for any quarter.
As reported for the quarter ended December 31, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Inseego Corp | 100.0% | Unchanged | 761,483 | $7.81M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 4 quarters.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tango Therapeutics Inc. | Exited | −26,961 | −$208K | — |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inseego Corp | New | +761,483 | +$12.4M | 98.4% |
| Inseego Corp | Exited | −761,483 | −$8.12M | — |
quarter ended June 30, 2024 · filed August 14, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 15, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mirati Therapeutics Inc | Exited | −3,135,966 | −$184M | — |
| Inseego Corp | Trimmed | −6,853,347 | −$19.2M | 90.9% |
Loading...
